BioCardia Announces DSMB Recommendation to Pause New Enrollment in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial While Additional Blinded Data is Collected
SUNNYVALE, Calif., July 24, 2023 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular…
OKSPOT Unveils Privacy-Focused Crypto Exchange for Global Traders With No-KYC Registration and Monero Support
Mambu and Mastercard expand cross-border payment capabilities for banks across APAC
Indonesia’s ITS Celebrates 66th Anniversary and Officially Closes KSTI 2026
Shaping the Future Together: Voices from Around the World at the III International Symposium ‘Creating the Future’ in Russia
The UAE’s AI Adoption Is a World Record. Paying for It Is Another Story